A patient decision aid for systemic lupus erythematosus improves shared decision-making and patient-provider communication in ...

Singer Selena Gomez's lupus-related arthritis diagnosis sheds light on how up to 90% of lupus patients experience joint pain, ...

A novel drug for systemic lupus erythematosus (SLE) first developed in China, and approved there since 2021, did well enough in a new placebo-controlled phase III trial that approval in Western ...

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...

In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of ...

A new study finds that EULAR/ACR criteria identify more systemic lupus erythematosus cases among patients with interstitial ...

Notably, 2 deaths occurred in the iscalimab group, 1 due to urosepsis and another associated with macrophage-activation syndrome. Opportunistic infections, including tuberculosis and herpes zoster, ...

Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T ...

Active LN and the presence of U1-RNP antibodies were linked to low BMD and osteoporosis among patients with SLE.

Introduction SLE is a chronic autoimmune disease characterised by multisystem involvement and fluctuating clinical course, ...

Wolves are returning to Europe, prompting both fear and delight. In forests west of Stockholm, Kate Maxwell and her daughter ...

GFR is key marker of kidney function; IgAN is progressive autoimmune kidney disease that leads to kidney failure in many patients1-3 Fabhalta is first and only approved complement inhibitor for adults ...